Azacitidine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Azacitidine Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Dec 18, 2020. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-771-39
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)
- Initial Posting
- Dec 18, 2020
Reason
Discontinuation of the manufacture of the drug